QQQ   349.38 (+0.40%)
AAPL   179.16 (+1.08%)
MSFT   328.75 (+0.11%)
META   271.40 (+2.52%)
GOOGL   123.47 (+0.49%)
AMZN   121.75 (+0.97%)
TSLA   202.71 (-0.60%)
NVDA   390.66 (+3.26%)
NIO   7.36 (-2.26%)
BABA   82.61 (+3.85%)
AMD   117.81 (-0.34%)
T   15.75 (+0.13%)
F   12.05 (+0.42%)
MU   68.69 (+0.72%)
CGC   0.84 (+1.09%)
GE   103.72 (+2.16%)
DIS   88.27 (+0.35%)
AMC   4.61 (+2.44%)
PFE   38.11 (+0.24%)
PYPL   63.00 (+1.63%)
NFLX   400.71 (+1.39%)
QQQ   349.38 (+0.40%)
AAPL   179.16 (+1.08%)
MSFT   328.75 (+0.11%)
META   271.40 (+2.52%)
GOOGL   123.47 (+0.49%)
AMZN   121.75 (+0.97%)
TSLA   202.71 (-0.60%)
NVDA   390.66 (+3.26%)
NIO   7.36 (-2.26%)
BABA   82.61 (+3.85%)
AMD   117.81 (-0.34%)
T   15.75 (+0.13%)
F   12.05 (+0.42%)
MU   68.69 (+0.72%)
CGC   0.84 (+1.09%)
GE   103.72 (+2.16%)
DIS   88.27 (+0.35%)
AMC   4.61 (+2.44%)
PFE   38.11 (+0.24%)
PYPL   63.00 (+1.63%)
NFLX   400.71 (+1.39%)
QQQ   349.38 (+0.40%)
AAPL   179.16 (+1.08%)
MSFT   328.75 (+0.11%)
META   271.40 (+2.52%)
GOOGL   123.47 (+0.49%)
AMZN   121.75 (+0.97%)
TSLA   202.71 (-0.60%)
NVDA   390.66 (+3.26%)
NIO   7.36 (-2.26%)
BABA   82.61 (+3.85%)
AMD   117.81 (-0.34%)
T   15.75 (+0.13%)
F   12.05 (+0.42%)
MU   68.69 (+0.72%)
CGC   0.84 (+1.09%)
GE   103.72 (+2.16%)
DIS   88.27 (+0.35%)
AMC   4.61 (+2.44%)
PFE   38.11 (+0.24%)
PYPL   63.00 (+1.63%)
NFLX   400.71 (+1.39%)
QQQ   349.38 (+0.40%)
AAPL   179.16 (+1.08%)
MSFT   328.75 (+0.11%)
META   271.40 (+2.52%)
GOOGL   123.47 (+0.49%)
AMZN   121.75 (+0.97%)
TSLA   202.71 (-0.60%)
NVDA   390.66 (+3.26%)
NIO   7.36 (-2.26%)
BABA   82.61 (+3.85%)
AMD   117.81 (-0.34%)
T   15.75 (+0.13%)
F   12.05 (+0.42%)
MU   68.69 (+0.72%)
CGC   0.84 (+1.09%)
GE   103.72 (+2.16%)
DIS   88.27 (+0.35%)
AMC   4.61 (+2.44%)
PFE   38.11 (+0.24%)
PYPL   63.00 (+1.63%)
NFLX   400.71 (+1.39%)
NASDAQ:CEMI

Chembio Diagnostics (CEMI) Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$0.45
▼
$0.46
50-Day Range
$0.33
▼
$0.46
52-Week Range
$0.19
▼
$1.24
Volume
351,600 shs
Average Volume
661,416 shs
Market Capitalization
$16.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

CEMI stock logo

About Chembio Diagnostics (NASDAQ:CEMI) Stock

Chembio Diagnostics, Inc. engages in the developing, manufacturing, marketing, and licensing of rapid medical tests. It offers rapid point-of-care tests for infectious, tropical and fever, and respiratory diseases, handheld analyzers, and veterinary products. The firm distributes its products to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers. The company was founded in 1985 and is headquartered in Medford, NY.

Receive CEMI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chembio Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

CEMI Stock News Headlines

May 25, 2023 | americanbankingnews.com
Chembio Diagnostics (NASDAQ:CEMI) Now Covered by Analysts at StockNews.com
May 17, 2023 | americanbankingnews.com
Chembio Diagnostics (NASDAQ:CEMI) Receives New Coverage from Analysts at StockNews.com
June 1, 2023 | Edge On The Street (Ad)
AI Getting Close to Thinking Like Humans
Technology experts working with neuroscientists have created the world's first Artificial Intelligence Network Operating System. AI can now process information like the human brain and understand the world the way humans do.
May 1, 2023 | americanbankingnews.com
Chembio Diagnostics (NASDAQ:CEMI) Coverage Initiated by Analysts at StockNews.com
April 28, 2023 | americanbankingnews.com
Chembio Diagnostics, Inc. (NASDAQ:CEMI) Major Shareholder Credit Advisors Ll Perceptive Buys 39,506 Shares
April 28, 2023 | americanbankingnews.com
Insider Buying: Chembio Diagnostics, Inc. (NASDAQ:CEMI) Major Shareholder Buys $31,590.00 in Stock
April 27, 2023 | finance.yahoo.com
Biosynex Completes Acquisition of Chembio Diagnostics, Inc.
April 27, 2023 | markets.businessinsider.com
Analysts Have Conflicting Sentiments on These Healthcare Companies: Laboratory (LH), Arbutus Biopharma (ABUS) and Chembio Diagnostics (CEMI)
June 1, 2023 | Edge On The Street (Ad)
The $193 Billion US-China War You Don't Know About
They're fighting for control of lithium – a key ingredient in EVs and clean energy technology. It's arguably the most important commodity of the 21st century. China owns 80% of global supply. But the US plans to grab a massive slice of the lithium market, which is forecasted to quadruple to $193 billion by 2028, according to Fortune Business Insights.
April 25, 2023 | americanbankingnews.com
Chembio Diagnostics (NASDAQ:CEMI) Research Coverage Started at StockNews.com
April 24, 2023 | americanbankingnews.com
Chembio Diagnostics (NASDAQ:CEMI) Coverage Initiated at StockNews.com
April 21, 2023 | americanbankingnews.com
Insider Buying: Chembio Diagnostics, Inc. (NASDAQ:CEMI) Major Shareholder Acquires 137,000 Shares of Stock
April 20, 2023 | benzinga.com
Shareholder Alert: Ademi LLP investigates whether Chembio Diagnostics, Inc. has obtained a Fair Price in its transaction with Biosynex
April 19, 2023 | finance.yahoo.com
Chembio Stockholders Urged to Tender Shares Before 6:00 P.M., New York City Time, on April 26, 2023
April 19, 2023 | americanbankingnews.com
Credit Advisors Ll Perceptive Purchases 140,134 Shares of Chembio Diagnostics, Inc. (NASDAQ:CEMI) Stock
April 14, 2023 | msn.com
Chembio Diagnostics And 2 Other Stocks Under $1 Insiders Are Aggressively Buying
April 14, 2023 | americanbankingnews.com
Chembio Diagnostics, Inc. (NASDAQ:CEMI) Major Shareholder Credit Advisors Ll Perceptive Buys 129,000 Shares
April 10, 2023 | finance.yahoo.com
Chembio Stockholders Reminded to Tender Shares Before 6:00 P.M., New York City Time, on April 12, 2023
April 3, 2023 | finance.yahoo.com
Chembio’s CEO Letter to Stockholders
March 28, 2023 | americanbankingnews.com
Chembio Diagnostics, Inc. (NASDAQ:CEMI) Sees Significant Decrease in Short Interest
March 21, 2023 | finance.yahoo.com
Chembio Stockholders Reminded to Tender Shares Before 6:00 PM New York City Time, on March 28, 2023
March 15, 2023 | finance.yahoo.com
Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.
March 15, 2023 | finance.yahoo.com
Chembio Announces Letter to Stockholders Regarding Tender Offer
February 24, 2023 | finance.yahoo.com
Chembio Announces the Receipt of CLIA Waiver for its DPP HIV-Syphilis System
February 8, 2023 | benzinga.com
Moore Kuehn Encourages ALBO, LPTX, ALR, and CEMI Investors to Contact Law Firm
February 2, 2023 | wsj.com
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Chembio Diagnostics, Inc. Buyout
February 1, 2023 | finance.yahoo.com
French Rapid Testing Company Scoops Up Chembio Diagnostics For $17M
See More Headlines


CEMI Company Calendar

Last Earnings
11/04/2021
Today
6/01/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CEMI
CUSIP
N/A
CIK
1092662
Web
www.chembio.com
Phone
(631) 924-1135
Fax
631-924-2065
Employees
337
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($1.20)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-23,290,000.00
Net Margins
-47.03%
Pretax Margin
-46.96%
Return on Equity
-113.57%
Return on Assets
-38.22%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.23
Quick Ratio
1.04

Sales & Book Value

Annual Sales
$48.34 million
Price / Sales
0.35
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.48 per share
Price / Book
0.95

Miscellaneous

Outstanding Shares
36,726,000
Free Float
35,514,000
Market Cap
$16.71 million
Optionable
Not Optionable
Beta
1.85

Key Executives

  • Richard L. Eberly
    President, Chief Executive Officer & Director
  • Paul J. Angelico
    Chief Operations Officer & Executive VP
  • Lawrence J. Steenvoorden
    Chief Financial Officer, Secretary & Executive VP
  • Javan Esfandiari
    Executive VP, Chief Science & Technology Officer
  • Atif Rizvi
    Vice President-Finance

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













CEMI Stock - Frequently Asked Questions

How were Chembio Diagnostics' earnings last quarter?

Chembio Diagnostics, Inc. (NASDAQ:CEMI) posted its quarterly earnings results on Thursday, November, 4th. The company reported ($0.24) EPS for the quarter, missing analysts' consensus estimates of ($0.19) by $0.05. The business had revenue of $12.06 million for the quarter. Chembio Diagnostics had a negative trailing twelve-month return on equity of 113.57% and a negative net margin of 47.03%. During the same period in the prior year, the firm earned ($0.28) EPS.

What other stocks do shareholders of Chembio Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chembio Diagnostics investors own include Prospect Capital (PSEC), Calumet Specialty Products Partners (CLMT), Two Harbors Investment (TWO), BlackRock Capital Investment (BKCC), NovoCure (NVCR), Viper Energy Partners (VNOM), Summit Midstream Partners (SMLP), Washington Prime Group (WPG), Roper Technologies (ROP) and ReWalk Robotics (RWLK).

What is Chembio Diagnostics' stock symbol?

Chembio Diagnostics trades on the NASDAQ under the ticker symbol "CEMI."

Who are Chembio Diagnostics' major shareholders?

Chembio Diagnostics' stock is owned by a variety of retail and institutional investors. Top institutional investors include Virtu Financial LLC (0.39%), HRT Financial LP (0.26%) and Simplex Trading LLC (0.00%).
View institutional ownership trends.

What is Chembio Diagnostics' stock price today?

One share of CEMI stock can currently be purchased for approximately $0.46.

How much money does Chembio Diagnostics make?

Chembio Diagnostics (NASDAQ:CEMI) has a market capitalization of $16.71 million and generates $48.34 million in revenue each year. The company earns $-23,290,000.00 in net income (profit) each year or ($1.20) on an earnings per share basis.

How many employees does Chembio Diagnostics have?

The company employs 337 workers across the globe.

How can I contact Chembio Diagnostics?

Chembio Diagnostics' mailing address is 555 WIRELESS BLVD., HAUPPAUGE NY, 11788. The official website for the company is www.chembio.com. The company can be reached via phone at (631) 924-1135, via email at investor@chembio.com, or via fax at 631-924-2065.

This page (NASDAQ:CEMI) was last updated on 6/1/2023 by MarketBeat.com Staff

My Account -